<unk>  is an anti-dyskinesia agent and antiparkinson agent that is FDA approved for the treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism.   Common adverse reactions include dyskinesia and nausea.
Carbidopa
Levodopa
Melevodopa
Droxidopa
Trifluperidol
Benperidol
Diphenidol
Bromperidol